Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center

INTRODUCTION: Fingolimod (Fg), a sphingosine 1-phosphate receptor modulator, decreases the annual relapse rate (ARR) in relapsing-remitting multiple sclerosis (RRMS). The aim of this study was to assess the efficacy and safety of Fg in daily practice in patients with RRMS, previously treated with na...

Descripción completa

Detalles Bibliográficos
Autores principales: Roux, Thomas, Maillart, Elisabeth, Vidal, Jean-Sébastien, Tezenas du Montcel, Sophie, Lubetzki, Catherine, Papeix, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418224/
https://www.ncbi.nlm.nih.gov/pubmed/28529497
http://dx.doi.org/10.3389/fneur.2017.00183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418224/
https://www.ncbi.nlm.nih.gov/pubmed/28529497
http://dx.doi.org/10.3389/fneur.2017.00183

Ejemplares similares